PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Sapienza Università di Roma, Dipartimento di Scienze Cliniche, Internistiche, Anestesiologiche e Cardiovascolari - Reumatologia, Roma, Italy.\', \'Translational Immunology Section, Office of Science and Technology, National Institute of Arthritis, Musculoskeletal and Skin Diseases, Bethesda, MD, USA. gadinama@mail.nih.gov.\']
?:citedBy
  • -1
?:creator
?:doi
  • eabc536710.1126/sciimmunol.abc5367
?:doi
?:hasPublicationType
?:journal
  • Science immunology
is ?:pmid of
?:pmid
?:pmid
  • 32385052
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • HiJAKing SARS-CoV-2? The potential role of JAK inhibitors in the management of COVID-19.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32385052>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32385052>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all